In Re: Aggrenox Antitrust Litigation

Track this case

Case overview

Case Number:

3:14-md-02516

Court:

Connecticut

Nature of Suit:

Anti-Trust

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Stefan R Underhill

Firms

Companies

Sectors & Industries:

  1. March 23, 2015

    Teva, Boehringer Trim 'Frankensteinian' Aggrenox Claims

    A Connecticut judge on Monday kept intact most federal claims against Teva Pharmaceuticals USA Inc. and Boehringer Ingelheim Pharmaceuticals Inc. alleging a pay-for-delay scheme over a generic version of stroke drug Aggrenox but gutted a "hodgepodge" of state claims the judge compared to Frankenstein's monster.

  2. July 16, 2014

    Teva Says It Doesn't Belong In Pay-For-Delay MDL

    Teva Pharmaceutical Industries Ltd. has asked a Connecticut federal court to be dismissed from antitrust class actions alleging a pay-for-delay scheme over a generic version of stroke drug Aggrenox, saying it is an Israeli company with only slight dealings with domestic subsidiaries accused of participating in the scheme.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!